In the initial TMA cohort, SERBP1 protein expression in breast carcinomas (IRS >2) was not associated with tumour size, lymph node status, histological grading, hormone receptor/Her2 status, focality or histological type of tumour (Additional file 2: Table S1). This evidence concerns the gene SERBP1 and neoplasm.